Health Canadas performance framework replaces older indicators tied to overall national drug spending with a new measure of pharmaceutical spending per capita, projected to fall between $1,212 and $1,340 by 202627
The central theme is misleading net impressiona longstanding OPDP enforcement framework under which FDA evaluates whether marketing, taken as a whole, could cause consumers to believe a compounded product is FDAapproved, FDAreviewed, or otherwise equivalent in any way, explicitly or implicitly, to an approved drug
Stop using Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting
This reminder matters because FDAs guidance has long taken a broad view of when a product is essentially a copy and when they can be compounded
Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, et al